Hoerter Steven L. — SEC Form 4 filings

SEC reporting owner CIK 1533451. 18 Form 4 filings on record with FilingPulse; latest filed 2026-08-04.

Transaction summary — filings shown

Covers all 18 filings on record, filed 2024-02-20 to 2026-08-04. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
MBX Biosciences, Inc. (MBX)President and CEO, Director101 leg · 20,000 sh · $264,98411
Deciphera Pharmaceuticals, Inc.President and CEO, Director29
C4 Therapeutics, Inc. (CCCC)Director33
Oric Pharmaceuticals, Inc. (ORIC)Director33

Form 4 filings — Hoerter Steven L.

FiledFormIssuerReported transactionsSource
2026-08-044MBX Biosciences, Inc. (MBX)Grant/award (A): 71,000 @ $0 · Grant/award (A): 331,000 (derivative) @ $0EDGAR
2026-06-264C4 Therapeutics, Inc. (CCCC)Grant/award (A): 62,000 (derivative) @ $0EDGAR
2026-06-054MBX Biosciences, Inc. (MBX)Grant/award (A): 12,500 (derivative) @ $0EDGAR
2026-05-044MBX Biosciences, Inc. (MBX)Grant/award (A): 11,938 @ $0 · Grant/award (A): 74,249 (derivative) @ $0EDGAR
2026-04-224/AMBX Biosciences, Inc. (MBX)Grant/award (A): 33,751 (derivative) @ $0EDGAR
2026-04-224/AMBX Biosciences, Inc. (MBX)Grant/award (A): 0 (derivative) @ $0EDGAR
2026-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2025-11-254MBX Biosciences, Inc. (MBX)Grant/award (A): 8,000 (derivative) @ $0EDGAR
2025-11-074MBX Biosciences, Inc. (MBX)Grant/award (A): 100,000 (derivative) @ $0EDGAR
2025-10-204MBX Biosciences, Inc. (MBX)Purchase (P): 20,000 @ $13.25EDGAR
2025-06-204C4 Therapeutics, Inc. (CCCC)Grant/award (A): 35,500 (derivative) @ $0EDGAR
2025-06-064MBX Biosciences, Inc. (MBX)Grant/award (A): 16,000 (derivative) @ $0EDGAR
2025-04-094MBX Biosciences, Inc. (MBX)Grant/award (A): 32,000 (derivative) @ $0EDGAR
2025-01-064Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 35,000 (derivative) @ $0EDGAR
2024-11-214C4 Therapeutics, Inc. (CCCC)Grant/award (A): 65,000 (derivative) @ $0EDGAR
2024-06-144Oric Pharmaceuticals, Inc. (ORIC)Grant/award (A): 25,600 (derivative) @ $0EDGAR
2024-06-114Deciphera Pharmaceuticals, Inc.Grant/award (A): 286,075 · Disposition to issuer (D): 286,075 · Code (U): 72,763 · Disposition to issuer (D): 395,735 (derivative) · Disposition to issuer (D): 270,357 (derivative) · Disposition to issuer (D): 415,000 (derivative) · +2 moreEDGAR
2024-02-204Deciphera Pharmaceuticals, Inc. (DCPH)Grant/award (A): 298,100 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1533451 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →